Discovery of Mitochondria-Targeting Berberine Derivatives As the Inhibitors of Proliferation, Invasion and Migration Against Rat C6 and Human U87 Glioma Cells

Shengnan Fu,Yanqi Xie,Jue Tuo,Yalong Wang,Wenbo Zhu,Sihan Wu,Guangmei Yan,Haiyan Hu

DOI: https://doi.org/10.1039/c4md00264d

2015-01-01

MedChemComm

Abstract:This research aims to synthesize lipophilic berberine derivatives and evaluate their antiglioma effects on C6 and U87 cells.

What problem does this paper attempt to address?

Berberine Inhibits Cell Growth Via Wnt/Beta-Catenin Signaling In Glioma

Dajiang Xie,Xinwei Li,Xuchen Qi,Yingfeng Wan,Yinxin Zhu,Shuxu Yang

2019-01-01

Abstract:Glioma is a common intracranial tumor, and the prognosis is poor, although much management is put into use. It has been reported that the Wnt/beta-catenin signaling pathway is associated with glioma. In the present study, berberine was investigated as an antineoplastic drug that inhibits Wnt/beta-catenin signaling pathway in growth of glioma cells in vitro. The results indicate that berberine inhibits cell proliferation and induces cell apoptosis. The expression levels of Wif-1 mRNA and protein in negative control (NC) cells were decreased significantly compared with berberine treated cells. Subsequent investigation revealed that berberine suppressed the activity of Wnt/beta-catenin signaling pathway and beta-catenin/TCF-4 transcription. Furthermore, expression of apoptosis-related protein Bcl-2 indicates cell apoptosis significantly. This study provides the first evidence that berberine reactivates Wif-1 from an inactive state and downregulates the canonical Wnt/beta-catenin signaling pathway. The findings identify berberine as an effective agent for glioma in vitro and may be a new therapeutic option in vivo.
Multiple Effects of Berberine Derivatives on Colon Cancer Cells

Luis Miguel Guamán Ortiz,Micol Tillhon,Michael Parks,Ilaria Dutto,Ennio Prosperi,Monica Savio,Andrea G. Arcamone,Franco Buzzetti,Paolo Lombardi,Anna Ivana Scovassi

DOI: https://doi.org/10.1155/2014/924585

2014-01-01

BioMed Research International

Abstract:The pharmacological use of the plant alkaloid berberine is based on its antibacterial and anti-inflammatory properties; recently, anticancer activity has been attributed to this compound. To exploit this interesting feature, we synthesized three berberine derivatives, namely, NAX012, NAX014, and NAX018, and we tested their effects on two human colon carcinoma cell lines, that is, HCT116 and SW613-B3, which are characterized by wt and mutated p53 , respectively. We observed that cell proliferation is more affected by cell treatment with the derivatives than with the lead compound; moreover, the derivatives proved to induce cell cycle arrest and cell death through apoptosis, thus suggesting that they could be promising anticancer drugs. Finally, we detected typical signs of autophagy in cells treated with berberine derivatives.

biotechnology & applied microbiology,medicine, research & experimental
9-O-Terpenyl-Substituted Berberrubine Derivatives Suppress Tumor Migration and Increase Anti-Human Non-Small-Cell Lung Cancer Activity

Jia-Ming Chang,Jin-Yi Wu,Shu-Hsin Chen,Wen-Ying Chao,Hsiang-Hao Chuang,Kam-Hong Kam,Pei-Wen Zhao,Yi-Zhen Li,Yu-Pei Yen,Ying-Ray Lee

DOI: https://doi.org/10.3390/ijms22189864

IF: 5.6

2021-09-13

International Journal of Molecular Sciences

Abstract:Lung cancer is one of the most common cancers and the leading cause of death in humans worldwide. Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases and is often diagnosed at a late stage. Among patients with NSCLC, 50% die within 1 year after diagnosis. Even with clinical intervention, the 5-year survival rate is only approximately 20%. Therefore, the development of an advanced therapeutic strategy or novel agent is urgently required for treating NSCLC. Berberine exerts therapeutic activity toward NSCLC; therefore, its activity as an antitumor agent needs to be explored further. In this study, three terpenylated-bromide derivatives of berberrubine were synthesized and their anti-NSCLC activities were evaluated. Each derivative had higher anti-NSCLCs activity than berberrubine and berberine. Among them, 9-O-gernylberberrubine bromide (B4) and 9-O-farnesylberberrubine bromide (B5) showed greater growth inhibition, cell-cycle regulation, in vitro tumorigenesis suppression, and tumor migration reduction. In addition, some degree of apoptosis and autophagic flux blocking was noted in the cells under B4 and B5 treatments. Our study demonstrates that the berberrubine derivatives, B4 and B5, exhibit impressive anti-NSCLC activities and have potential for use as chemotherapeutic agents against NSCLC.

biochemistry & molecular biology,chemistry, multidisciplinary
Dehydroberberine Analogue Nanoassemblies for Inducing and Self-Reporting Mitochondrial Dysfunction in Tumor Cells

Rui Zhang,Ruibing An,Zhanni Gu,Haifeng Sun,Deju Ye,Hong Liu

DOI: https://doi.org/10.1021/acsabm.0c00747

2021-01-01

ACS Applied Bio Materials

Abstract:Mitochondria-targeting probes that allow us to induce and report mitochondrial dysfunction have become promising theranostic agents for cancer; however, the lack of selectivity toward tumor cells over normal tissue cells has impeded the treatment outcome. Herein, we develop 10 fluorescent dehydroberberine derivatives (B1-B10) capable of lighting up mitochondria and exerting moderate cytotoxicity against tumor cells. To enable the selectivity toward tumor cells over normal tissue cells, we introduced a lipophilic anion tetraphenylborate (TPB-) into the most potent compound B3(+)Cl(-) to drive molecular self-assembly into monodisperse organic nanoassemblies (B3NPs) in aqueous solution, which efficiently enhance the delivery of B3(+) into HeLa cells assisted by an electrostatic interaction-driven anion-exchange process. Fluorescence imaging reveals that B3(+) can initially accumulate in the mitochondria after entering HeLa cells, followed by inducing mitochondrial dysfunction and then migrating into the nucleus. Strong B3(+) fluorescence translocating from mitochondria to nucleus can be monitored in real-time, allowing for self-reporting of mitochondrial dysfunction in HeLa cells. Moreover, we demonstrate that B3NPs exert significantly higher cytotoxicity against seven different tumor cells (e.g., U87MG, HeLa, MDA-MB-468, MDA-MB-435, MDA-MB-231, MCF-7, and HCT116 cells) compared to human normal tissue cells (e.g., HUVEC, HEK293). This work highlights the utility of the self-assembly approach to improve the cytotoxicity and selectivity of mitochondria-targeting agents against tumor cells.
Mitochondria play an important role in the cell proliferation suppressing activity of berberine

Xiao-Jin Yan,Xuan Yu,Xin-Pei Wang,Jing-Fei Jiang,Zhi-Yi Yuan,Xi Lu,Fan Lei,Dong-Ming Xing

DOI: https://doi.org/10.1038/srep41712

IF: 4.6

2017-01-01

Scientific Reports

Abstract:After being studied for approximately a century, berberine (BBR) has been found to act on various targets and pathways. A great challenge in the pharmacological analysis of BBR at present is to identify which target(s) plays a decisive role. In the study described herein, a rescue experiment was designed to show the important role of mitochondria in BBR activity. A toxic dose of BBR was applied to inhibit cell proliferation and mitochondrial activity, then α-ketobutyrate (AKB), an analogue of pyruvate that serves only as an electron receptor of NADH, was proven to partially restore cell proliferation. However, mitochondrial morphology damage and TCA cycle suppression were not recovered by AKB. As the AKB just help to regenerate NAD+, which is make up for part function of mitochondrial, the recovered cell proliferation stands for the contribution of mitochondria to the activity of BBR. Our results also indicate that BBR suppresses tumour growth and reduces energy charge and mitochondrial DNA (mtDNA) copy number in a HepG2 xenograft model. In summary, our study suggests that mitochondria play an important role in BBR activity regarding tumour cell proliferation and metabolism.
Berberine Inhibits Glioma Cell Migration and Invasion by Suppressing TGF-β1/COL11A1 Pathway and Enhances Chemosensitivity

Yuxue Sun,Haiyan Huang,Zhixin Zhan,Haijun Gao,Chaochao Zhang,Jiacheng Lai,Junguo Cao,Chaoyue Li,Yong Chen,Ziqiang Liu

DOI: https://doi.org/10.21203/rs.3.rs-1107663/v1

2021-12-20

Abstract:Abstract Background: The expression of collagen type XI alpha 1 chain (COL11A1) is up-regulated in many cancers, affecting the risk of metastasis, drug resistance, and poor prognosis. Berberine is an isoquinoline alkaloid present in many traditional Chinese medicines and it has been shown to reduce collagen accumulation in pulmonary fibrosis, diabetic nephropathy and arthritis. However, its effect on COL11A1 in glioma needs to be further elucidated. Methods: Western blot was performed to detect the expression level of COL11A1 in several glioma cells, and siCOL11A1 was performed to investigate the effect of COL11A1 on the migration and invasion ability of glioma cells. CCK-8, wound healing experiment and transwell experiment were performed to detect the effect of berberine on the proliferation, migration and invasion of glioma cells. The xenografts experiment in nude mice was performed to test the effect of berberine on inhibiting glioma in vivo . Results: Our results showed that COL11A1 is highly expressed in glioma cell lines and associated with migration, invasion, and chemoresistance of glioma cells. Knocking down COL11A1 caused decreased expression of MMPs, Snail, and MGMT. Berberine could inhibit the migration and invasion of glioma cells by suppressing the TGF-β1/COL11A1 pathway and changes actin cytoskeleton arrangement. In addition, berberine increased the chemosensitivity of glioma cells to temozolomide, which may be related to the down-regulation of Snail and MGMT proteins caused by berberine. High-throughput sequencing of xenografts in nude mice also showed that berberine inhibited the expression of COL11A1 in vivo . Conclusions: Our results suggest that berberine that targets COL11A1 to inhibit glioma migration, invasion and chemoresistance, may serve as a promising candidate for the development of anti-glioma drugs in the future.
Berberine inhibits glioma cell migration and invasion by suppressing TGF-β1/COL11A1 pathway

Yuxue Sun,Haiyan Huang,Zhixin Zhan,Haijun Gao,Chaochao Zhang,Jiacheng Lai,Junguo Cao,Chaoyue Li,Yong Chen,Ziqiang Liu

DOI: https://doi.org/10.1016/j.bbrc.2022.07.101

2022-10-15

Abstract:Glioma is a clinically heterogeneous disease with a poor prognosis. Berberine (BBR), as a multi-target anti-tumor alkaloid, has the ability to penetrate the blood-brain barrier and shows cytotoxicity to glioma cells. In previous studies, we demonstrated that berberine inhibits glioma cell proliferation by inhibiting mutant p53 protein and promoting mitochondrial damage. In addition, berberine has been shown to reduce collagen accumulation in pulmonary fibrosis, diabetic nephropathy and arthritis. However, its effect on collagen in cancer needs to be further elucidated. In this study, we proved that the collagen XI alpha 1 chain (COL11A1) is highly expressed in glioma cell lines and associated with migration and invasion of glioma cells. Knocking down COL11A1 caused decreased expression of MMPs. Berberine could inhibit the migration and invasion of glioma cells by suppressing the TGF-β1/COL11A1 pathway and changes actin cytoskeleton arrangement. Nude mouse subcutaneous xenografts model also showed that berberine inhibited the expression of COL11A1 in vivo. Collectively, berberine that targets COL11A1 to inhibit glioma migration and invasion, may serve as a promising candidate for the development of anti-glioma drugs in the future.
Research progress on the pharmacological effects of berberine targeting mitochondria

Xinyi Fang,Haoran Wu,Jiahua Wei,Runyu Miao,Yanjiao Zhang,Jiaxing Tian

DOI: https://doi.org/10.3389/fendo.2022.982145

IF: 6.055

2022-08-11

Frontiers in Endocrinology

Abstract:Berberine is a natural active ingredient extracted from the rhizome of Rhizoma Coptidis , which interacts with multiple intracellular targets and exhibits a wide range of pharmacological activities. Previous studies have preliminarily confirmed that the regulation of mitochondrial activity is related to various pharmacological actions of berberine, such as regulating blood sugar and lipid and inhibiting tumor progression. However, the mechanism of berberine’s regulation of mitochondrial activity remains to be further studied. This paper summarizes the molecular mechanism of the mitochondrial quality control system and briefly reviews the targets of berberine in regulating mitochondrial activity. It is proposed that berberine mainly regulates glycolipid metabolism by regulating mitochondrial respiratory chain function, promotes tumor cell apoptosis by regulating mitochondrial apoptosis pathway, and protects cardiac function by promoting mitophagy to alleviate mitochondrial dysfunction. It reveals the mechanism of berberine’s pharmacological effects from the perspective of mitochondria and provides a scientific basis for the application of berberine in the clinical treatment of diseases.

endocrinology & metabolism
Synthesis and Anticancer Activity of Novel 9-O-Substituted Berberine Derivatives

Viktor Milata,Alexandra Svedova,Zuzana Barbierikova,Eva Holubkova,Ingrid Cipakova,Dana Cholujova,Jana Jakubikova,Miroslav Panik,Sona Jantova,Vlasta Brezova,Lubos Cipak

DOI: https://doi.org/10.3390/ijms20092169

IF: 5.6

2019-05-01

International Journal of Molecular Sciences

Abstract:Berberine is a bioactive isoquinoline alkaloid derived from many plants. Although berberine has been shown to inhibit growth and induce apoptosis of several tumor cell lines, its poor absorption and moderate activity hamper its full therapeutic potential. Here, we describe the synthesis of a series of 9-O-substituted berberine derivatives with improved antiproliferative and apoptosis-inducing activities. An analysis of novel berberine derivatives by EPR spectroscopy confirmed their similar photosensitivity and analogous behavior upon UVA irradiation as berberine, supporting their potential to generate ROS. Improved antitumor activity of novel berberine derivatives was revealed by MTT assay, by flow cytometry and by detection of apoptotic DNA fragmentation and caspase-3 activation, respectively. We showed that novel berberine derivatives are potent inhibitors of growth of HeLa and HL-60 tumor cell lines with IC50 values ranging from 0.7 to 16.7 μM for HL-60 cells and 36 to >200 μM for HeLa cells after 48 h treatment. Further cell cycle analysis showed that the observed inhibition of growth of HL-60 cells treated with berberine derivatives was due to arresting these cells in the G2/M and S phases. Most strikingly, we found that berberine derivative 3 (9-(3-bromopropoxy)-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a] isoquinolin-7-ylium bromide) possesses 30-fold superior antiproliferative activity with an IC50 value of 0.7 μM and 6-fold higher apoptosis-inducing activity in HL-60 leukemia cells compared to berberine. Therefore, further studies are merited of the antitumor activity in leukemia cells of this berberine derivative.

biochemistry & molecular biology,chemistry, multidisciplinary
Self-assembly of Fluorescent Dehydroberberine Enhances Mitochondria-Dependent Antitumor Efficacy.

Runqi Yan,Haifeng Sun,Hong Liu,Ruibing An,Deju Ye,Zhanni Gu,Yuxuan Hu

DOI: https://doi.org/10.1002/chem.201801112

2018-06-21

Chemistry

Abstract:Selective imaging and inducing mitochondrial dysfunction in tumor cells using mitochondria-targeting probes has become as a promising approach for cancer diagnosis and therapy. Here, we report the design of a fluorescent berberine analog, dehydroberberine (DH-BBR), as a new mitochondria-targeting probe capable of self-assembling into monodisperse organic nanoparticles (DTNPs) upon integration with a lipophilic counter anion, allowing for enhanced fluorescence imaging and treatment of tumors in living mice. X-ray crystallography revealed that the self-assembly process was attributed to a synergy of different molecular interactions, including π-π stacking, O⋅⋅⋅π interaction and electrostatic interaction between DH-BBR and counter anions. We demonstrated that DTNPs could efficiently enter tumor tissue following intravenous injection and enhance mitochondrial delivery of DH-BBR via an electrostatic interaction driven anion exchange process. Selective accumulation in the mitochondria capable of emitting strong fluorescence and causing mitochondrial dysfunction was achieved, enabling efficient inhibition of tumor growth in living mice. This study demonstrates promise for applying lipophilic anions to control molecular self-assembly and tune antitumor activity of mitochondria-targeting probes, which can facilitate to improve cancer treatment in vivo.

Chemistry,Medicine
A Novel Delivery System for the Combined Use of Natural Ingredients: The Preparation of Berberine Hydrochloride–Matrine Liposomes and Preliminary Exploration of Their Anti-Tumor Activity

Min Xu,Zhangkai Ye,JunJing Liu,Shunpeng Zhu,Yuchen Chen,Jia Cai,Yangxi Chen,Long Wang,Liang Zhang,Qiang Ye

DOI: https://doi.org/10.3390/molecules29215210

IF: 4.6

2024-11-04

Molecules

Abstract:Berberine hydrochloride (BH) extracted from Coptis chinensis (CC) and Matrine (MT) separated from Sophora flavescens (SF) are alkaloids with potent anti-bacterial, anti-inflammatory, and anti-tumor effects. Motivated by the clinical practice of using CC and SF together, we aimed to demonstrate that the synergistic application of the natural compounds BH and MT could enhance therapeutic effects and minimize side effects. Two types of liposomes, liposomes containing only BH (BH-LP) and liposomes containing both BH and MT (BH-MT-LP), were successfully prepared via the reverse evaporation method. The liposome preparation process was optimized by single-factor screening and the Box–Behnken experimental design method. The results showed that the liposomes had particle sizes in the range of 222.7 to 235.4 nm, polydispersity indicated in the range of 11.8% to 23.3%, and zeta potentials in the range of −35.9 to −31.1 mv. BH-MT-LP showed superior anti-tumor activity against MDA-MB-231, HepG-2, and HGC-27 cells in vitro. The incorporation of MT effectively promoted the anti-tumor effect of BH, while the controlled release from liposomes further enhanced the therapeutic efficacy of BH. Furthermore, based on the flow cytometry results, we speculated that BH-MT-LP might promote apoptosis by blocking the G1 phase of cells and inducing cell death. In conclusion, BH-MT-LP provides evidence for the combined use of natural compounds as a stable, safe, and practical drug delivery system for the treatment of potential cancers. Meanwhile, the successful preparation for BH-MT-LP also provides a new approach to the combined use of traditional Chinese medicine ingredients.

chemistry, multidisciplinary,biochemistry & molecular biology
Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system

Kun Zou,Zhao Li,Yong Zhang,Hao-yue Zhang,Bo Li,Wei-liang Zhu,Ji-ye Shi,Qi Jia,Yi-ming Li

DOI: https://doi.org/10.1038/aps.2016.125

IF: 7.169

2016-12-05

Acta Pharmacologica Sinica

Abstract:It has been widely recognized that inflammation, particularly chronic inflammation, can increase the risk of cancer and that the simultaneous treatment of inflammation and cancer may produce excellent therapeutic effects. Berberine, an alkaloid isolated from Rhizoma coptidis, has broad applications, particularly as an antibacterial agent in the clinic with a long history. Over the past decade, many reports have demonstrated that this natural product and its derivatives have high activity against both cancer and inflammation. In this review, we summarize the advances in studing berberine and its derivatives as anti-inflammatory and anti-tumor agents in the digestive system; we also discuss their structure-activity relationship. These data should be useful for the development of this natural product as novel anticancer drugs with anti-inflammation activity.

pharmacology & pharmacy,chemistry, multidisciplinary
An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology

Pengfei Guo,Chuipu Cai,Xiaoqin Wu,Xiude Fan,Wei Huang,Jingwei Zhou,Qihui Wu,Yujie Huang,Wei Zhao,Fengxue Zhang,Qi Wang,Yongbin Zhang,Jiansong Fang

DOI: https://doi.org/10.3389/fphar.2019.00857

IF: 5.6

2019-08-06

Frontiers in Pharmacology

Abstract:Over the past several decades, natural products with poly-pharmacological profiles have demonstrated promise as novel therapeutics for various complex diseases, including cancer. Berberine (PubChem CID: 2353), a soliloquies quaternary alkaloid, has been validated to exert powerful effects in many cancers. However, the underlying molecular mechanism is not yet fully elucidated. In this study, we summarized the molecular effects of berberine against multiple cancers based on current available literatures. Furthermore, a systems pharmacology infrastructure was developed to discover new cancer indications of berberine and explore their molecular mechanisms. Specifically, we incorporated 289 high-quality protein targets of berberine by integrating experimental drug–target interactions (DTIs) extracted from literatures and computationally predicted DTIs inferred by network-based inference approach. Statistical network models were developed for identification of new cancer indications of berberine through integration of DTIs and curated cancer significantly mutated genes (SMGs). High accuracy was yielded for our statistical models. We further discussed three typical cancer indications (hepatocarcinoma, lung adenocarcinoma, and bladder carcinoma) of berberine with new mechanisms of actions (MOAs) based on our systems pharmacology framework. In summary, this study systematically provides a powerful strategy to identify potential anti-cancer effects of berberine with novel mechanisms from a systems pharmacology perspective.

pharmacology & pharmacy
[Research progress in mechanism of berberine's antitumor action].

Tao Chen,Li-Jin Zhang,Yuyuan Gong,Xianhua Yang,Maohui Luo,Shuai Luo

DOI: https://doi.org/10.19540/j.cnki.cjcmm.20210209.601

2021-05-01

Abstract:Malignant tumor, an important factor threatening human life and health, brings huge economic burden to patients. At present, chemoradiotherapy is still the main treatment method for tumor diseases, but there are also great side effects when it plays a therapeutic role. Traditional Chinese medicine in the prevention and treatment of tumor diseases has many advantages such as few side effects, improving the physiological state of patients, and slowing down the side effects of radiotherapy and chemotherapy. Berberine is an effective component of rhizoma coptidis, with a very good antitumor effect. It can inhibit tumor cell proliferation, promote tumor cell apoptosis, inhibit tumor metastasis and angiogenesis, regulate tumor autophagy, reverse multi-drug resistance of tumor, regulate the body immunity, and affect tumor metabolic reprogramming to play its role. Compared with chemical preparations, berberine has a wide range of sources, with high safety and easy access, and has great potential in the prevention and treatment of malignant tumors. In this article, we would mainly review the research progress on the antitumor mechanism of berberine in recent years.

Medicine
Synthesis of hydrophobically modified berberine derivatives with high anticancer activity through modulation of the MAPK pathway

Lizhen Wang,Xueliang Yang,Xiaobin Li,Rostyslav Stoika,Xue Wang,Houwen Lin,Yukui Ma,Rongchun Wang,Kechun Liu

DOI: https://doi.org/10.1039/d0nj01645d

IF: 3.3

2020-01-01

New Journal of Chemistry

Abstract:Linoleic acid-modified berberine derivative induces apoptosis of A549 cells and affects the expression of proteins associated with the MAPK pathway.

chemistry, multidisciplinary
High-brightness photocathodes through ultrathin surface layers on metals.

K. Németh,K. Harkay,M. van Veenendaal,L. Spentzouris,M. White,K. Attenkofer,G. Srajer

DOI: https://doi.org/10.1103/PHYSREVLETT.104.046801

IF: 8.6

2010-01-26

Physical Review Letters

Abstract:We report how ultrathin MgO films on Ag(001) surfaces can be used to control the emittance properties of photocathodes. In addition to substantially reducing the work function of the metal surface, the MgO layers also favorably influence the shape of the surface bands resulting in the generation of high-brightness electron beams. As the number of MgO surface layers varies from 0 to 3, the emitted electron beam becomes gradually brighter, reducing its transverse emittance to 0.06 mm mrad. We suggest the use of such photocathodes for the development of free-electron x-ray lasers and energy-recovery linac x-ray sources.
Berberine Suppressed the Progression of Human Glioma Cells by Inhibiting the TGF-β1/SMAD2/3 Signaling Pathway

Yun Jin,Jiawei Zhang,Yunfeng Pan,Wangzhen Shen

DOI: https://doi.org/10.1177/15347354221130303

2022-10-20

Integrative Cancer Therapies

Abstract:Integrative Cancer Therapies, Volume 21, Issue , January-December 2022. Background:Previous studies have shown that berberine can inhibit glioma progression, although the underlying molecular mechanisms needed to be explored further. The aim of this study was to evaluate the suppressive effects of berberine on human glioma cells, and identify the underlying signaling pathways.Material and Methods:The cytotoxic effect of different concentrations of berberine against normal human glial cells (HEB) and 4 glioma cell lines was evaluated by the CCK-8 assay. Apoptosis was assayed by flow cytometry. In vitro migration and invasion were analyzed by the wound healing and transwell assays. The expression levels of specific proteins were measured by western blotting and ELISA.Results:Berberine significantly inhibited the proliferation of human glioma U-87 cells, and induced apoptosis in the U-87 and LN229 cells by downregulating Bcl-2, and upregulating Bax and caspase-3. In addition, berberine also inhibited migration and invasion of the glioma cells. Furthermore, berberine exerted its effects on the proliferation, migration, invasion, and apoptosis of glioma cells by inhibiting the TGF-β1/SMAD2/3 signaling pathway, and exogenous TGF-β abrogated the pro-apoptotic and anti-oncogenic effects of berberine.Conclusions:Berberine inhibits glioma progression by targeting the TGF-β1/SMAD2/3 signaling pathway.

oncology,integrative & complementary medicine
The Anti-Glioma Effect of Juglone Derivatives through ROS Generation

Jinsen Zhang,Minjie Fu,Jinfeng Wu,Fengfeng Fan,Xin Zhang,Chunjie Li,Hui Yang,Yonghe Wu,Yiming Yin,Wei Hua

DOI: https://doi.org/10.3389/fphar.2022.911760

IF: 5.6

2022-06-14

Frontiers in Pharmacology

Abstract:Juglone has been extensively reported as a natural antitumor pigment. However, it is easy to be oxidized due to active hydroxy in the quinone. Here, we designed some new juglone derivatives, as the hydroxy was replaced by methyl (D1), allyl (D2), butyl (D3), and benzyl (D4) groups. Nuclear magnetic resonance spectra and mass spectrometry were applied to confirm the derivatives and oxidative products of juglone. U87 and U251 cell lines were used for tests in vitro , and primary human glioblastoma cells were applied for in vivo experiments. The CCK8 and EdU assay demonstrated the anti-tumor effect of the four derivatives, and IC50 for U87 was 3.99, 3.28, 7.60, and 11.84 μM, respectively. In U251, IC50 was 7.00, 5.43, 8.64, and 18.05 μM, respectively. D2 and D3 were further selected, and flow cytometry showed that apoptosis rates were increased after D2 or D3 treatment via ROS generation. Potential targets were predicted by network pharmacology analysis, most of which were associated with apoptosis, cell cycle, and metabolism pathway. CDC25B and DUSP1 were two of the most likely candidates for targets. The orthotopic glioblastoma model was established to evaluate the anti-glioma effect and side-effect of juglone derivatives, and the in vivo experiments confirmed the anti-glioma effects of juglone derivatives. In conclusion, new derivatives of juglone were created via chemical group substitution and could inhibit glioma cell viability and proliferation and induce apoptosis rate via ROS generation.

pharmacology & pharmacy
Synthesis, Biological Evaluation and Action Mechanism Study of New Mitochondria-Targeted Curcumin Derivative as Potential Antitumor Drugs

Zhuhang Lu,Ziwei Gao,Haoying Song,Ying Zhou,Wei Yuan,Xuelian Wang,Luxi Zhang,Yi Hong,Yan Meng,Junjie Hu,Guohua Zheng,Cong Chang

DOI: https://doi.org/10.1002/cbdv.202300086

Abstract:Mitochondria have emerged as important targets in cancer therapy due to their key role in regulating energy supply, maintaining redox homeostasis, and intrinsic apoptosis. Curcumin (CUR) has shown promise in inhibiting the proliferation and metastasis of cancer cells by inducing apoptosis and arresting cell cycle. However, the clinical application of CUR has been limited by its low stability and poor tumor selectivity. To address these issues, the novel mitochondria-targeted curcumin derivatives were synthesized through the unilateral coupling (CUR-T) or bilateral coupling (CUR-2T) of curcumin's phenolic hydroxy groups with triphenyl phosphorus via ester bond. The aim was to achieve better stability, higher tumor selectivity, and stronger curative efficacy. The results of stability and biological experiments indicated that both stability and cytotoxicity were arranged in descending order of CUR-2T>CUR-T>CUR. In ovarian cancer cells (A2780 cells), CUR-2T showed well-defined preferential selectivity towards cancer cells and exhibited efficient anticancer efficacy due to its superior mitochondria accumulation ability. Subsequently, the mitochondrial redox balance was disrupted, accompanied by increased ROS levels, decreased ATP levels, dissipated MMP, and increased G0 /G1 phase arrest, leading to a higher apoptotic rate. In summary, the results of this study suggest that CUR-2T holds substantial promise for further development as a potential agent for the treatment of ovarian cancer.
Precision Delivery of Binary Cooperative Nanodrugs Self-Assembled by Berberine Glycyrrhetinic Acid Salts for Hepatocellular Carcinoma Treatment

Yang Xiao,Alu Ouyang,Ling Fan,Xin Qin,Yu Li,Zixin Wang,Pingyun Yuan,Xuejing Huang,Jie Hao,Hongyan Zhu,Qiuju Huang,Hongwei Guo,Ronghua Jin

DOI: https://doi.org/10.1021/acsami.4c15320

IF: 9.5

2024-10-18

ACS Applied Materials & Interfaces

Abstract:Berberine (BB) has demonstrated significant inhibitory effects on tumorigenesis and progression. However, its clinical application is hindered by challenges such as low bioavailability due to limited cell membrane permeability, nontargeted accumulation away from solid tumors, and increased toxicity associated with intravenous administration. To overcome these challenges, a lipophilic salt-forming strategy was employed to enhance lipophilicity, thereby promoting membrane permeability and...

materials science, multidisciplinary,nanoscience & nanotechnology

Discovery of Mitochondria-Targeting Berberine Derivatives As the Inhibitors of Proliferation, Invasion and Migration Against Rat C6 and Human U87 Glioma Cells

Berberine Inhibits Cell Growth Via Wnt/Beta-Catenin Signaling In Glioma

Multiple Effects of Berberine Derivatives on Colon Cancer Cells

9-O-Terpenyl-Substituted Berberrubine Derivatives Suppress Tumor Migration and Increase Anti-Human Non-Small-Cell Lung Cancer Activity

Dehydroberberine Analogue Nanoassemblies for Inducing and Self-Reporting Mitochondrial Dysfunction in Tumor Cells

Mitochondria play an important role in the cell proliferation suppressing activity of berberine

Berberine Inhibits Glioma Cell Migration and Invasion by Suppressing TGF-β1/COL11A1 Pathway and Enhances Chemosensitivity

Berberine inhibits glioma cell migration and invasion by suppressing TGF-β1/COL11A1 pathway

Research progress on the pharmacological effects of berberine targeting mitochondria

Synthesis and Anticancer Activity of Novel 9-O-Substituted Berberine Derivatives

Self-assembly of Fluorescent Dehydroberberine Enhances Mitochondria-Dependent Antitumor Efficacy.

A Novel Delivery System for the Combined Use of Natural Ingredients: The Preparation of Berberine Hydrochloride–Matrine Liposomes and Preliminary Exploration of Their Anti-Tumor Activity

Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system

An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology

[Research progress in mechanism of berberine's antitumor action].

Synthesis of hydrophobically modified berberine derivatives with high anticancer activity through modulation of the MAPK pathway

High-brightness photocathodes through ultrathin surface layers on metals.

Berberine Suppressed the Progression of Human Glioma Cells by Inhibiting the TGF-β1/SMAD2/3 Signaling Pathway

The Anti-Glioma Effect of Juglone Derivatives through ROS Generation

Synthesis, Biological Evaluation and Action Mechanism Study of New Mitochondria-Targeted Curcumin Derivative as Potential Antitumor Drugs

Precision Delivery of Binary Cooperative Nanodrugs Self-Assembled by Berberine Glycyrrhetinic Acid Salts for Hepatocellular Carcinoma Treatment